what is atenolol It’s not just about showing off. For the woman, Judith Saunders, who fought for her wedding ring back, she’s not fighting for a £550 ring but for an object with real personal meaning. Even for those who are bitterly divorced, a wedding ring is a sign of the hope before the reality; a time when couples are willing to pour their money into an item of jewellery for the sake of announcing their love to the world. " />
Français | English
Texte size: A A A XML

Stewart Cole, professeur ordinaire de pathogenèse microbienne à la Faculté des sciences de la vie (FSV)
See also

A Pioneer in Tuberculosis and Leprosy Genomes

14 December 2006

Stewart Cole leaves Paris for the EPFL

Stewart Cole, who was until recently the Scientific Director of the Institut Pasteur, is joining the Ecole polytechnique fédérale de Lausanne (EPFL). He is going to help create the Global Health Institute, a centre that will use cutting-edge techniques to seek solutions to tuberculosis, a growing threat worldwide.

The Board of the Swiss Federal Institutes of Technology announced today the appointment of Stewart Cole as Full Professor of microbial pathogenesis at the School of Life Sciences. A key figure at the Institut Pasteur in Paris, where he was the Scientific Director, this 51-year-old professor, a native of Wales, will take up his post at the Global Health Institute in the fall of 2007. The Institute's mission is to understand dangerous infectious diseases such as AIDS, malaria and tuberculosis so as to better treat and prevent them. Dr Cole is an internationally known researcher who will focus on developing drugs, vaccines and diagnostic tools, for which he already holds a number of patents as the inventor or co-inventor, in particular tools for detecting antibiotic-resistant bacteria. 
Dr Cole's work on tuberculosis, leprosy, AIDS, gas gangrene and bacterial molecular genetics is widely acclaimed throughout the world. He was a leading member of the team of scientists who determined the complete nucleotide sequence for the AIDS virus. He is also considered to be a pioneer in the genomics of tuberculosis and leprosy bacilli.
At the EPFL, his obvious interest in drug discoveries should create synergies with other areas such as biochemistry and computer science. His arrival, along with that of another well-known specialist, John McKinney of The Rockefeller University, marks the opening of a centre of excellence devoted to tuberculosis. These appointments represent two different but complementary approaches to the disease. The press release concerning John McKinney's appointment is available at http://actualites.epfl.ch/comm.
Dr Cole studied biology at the University of Wales prior to earning his doctorate from the University of Sheffield in 1979. Subsequently he embarked on a career as a researcher at the University of Umea (Sweden) and the Max Planck Institut in Tuebingen (Germany), and then at the Institut Pasteur, where he was in turn a senior research fellow, the head of the bacterial molecular genetics unit, a professor, and finally the Director of Strategic Technologies from 2000 to 2004. Since that time, he has been the Institute's Scientific Director. Dr Cole was made a Knight of the Legion of Honour for services rendered to science.

journaliste: Florence Luy